Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2677 |
|
| Actual shortage: | 256 (10%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2412 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
24 (9%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-FENTANYL | 100MCG | PATCH | Resolved | 2020-04-23 | 2020-05-21 | 113025 |
| TEVA-FENTANYL | 100MCG | PATCH | Resolved | 2022-02-24 | 2022-04-09 | 155560 |
| TEVA-FENTANYL | 25MCG | PATCH | Resolved | 2022-03-24 | 2022-04-09 | 157247 |
| TEVA-FENTANYL | 50MCG | PATCH | Resolved | 2022-06-30 | 2022-08-09 | 163936 |
| TEVA-FENTANYL | 100MCG | PATCH | Resolved | 2022-06-30 | 2022-09-23 | 163939 |
| TEVA-FENTANYL | 50MCG | PATCH | Resolved | 2022-08-18 | 2022-09-23 | 167218 |
| TEVA-FENTANYL | 75MCG | PATCH | Resolved | 2022-10-28 | 2022-12-02 | 173013 |
| TEVA-FENTANYL | 50MCG | PATCH | Resolved | 2022-10-28 | 2022-12-02 | 173016 |
| TEVA-FENTANYL | 25MCG | PATCH | Resolved | 2022-10-28 | 2022-12-02 | 173019 |
| TEVA-FENTANYL | 12MCG | PATCH | Resolved | 2022-10-28 | 2022-12-02 | 173022 |
| TEVA-FENTANYL | 100MCG | PATCH | Resolved | 2022-10-28 | 2022-12-02 | 173025 |
| TEVA-FENTANYL | 12MCG | PATCH | Resolved | 2023-01-12 | 2023-06-09 | 180909 |
| TEVA-FENTANYL | 50MCG | PATCH | Resolved | 2023-08-17 | 2023-10-04 | 202265 |
| TEVA-FENTANYL | 100MCG | PATCH | Resolved | 2024-01-25 | 2024-05-09 | 217223 |
| TEVA-FENTANYL | 25MCG | PATCH | Actual shortage | 2024-02-01 | 2024-04-25 | 218132 |
| TEVA-FENTANYL | 25MCG | PATCH | Resolved | 2024-02-01 | 2024-02-01 | 218134 |
| TEVA-FENTANYL | 50MCG | PATCH | Actual shortage | 2024-02-01 | 2024-04-25 | 218137 |
| TEVA-FINASTERIDE | 5MG | TABLET | Resolved | 2017-08-21 | 2017-10-10 | 19944 |
| TEVA-FINASTERIDE | 5MG | TABLET | Resolved | 2020-05-01 | 2020-05-29 | 113785 |
| TEVA-FINASTERIDE | 5MG | TABLET | Resolved | 2021-09-30 | 2021-10-07 | 146459 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-TRIMEL | 400MG 80MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106133 |
| TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65020 |
| TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65023 |
| TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
| TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | To be discontinued | 2019-07-05 | 2019-07-05 | 88619 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |